Anne Goubier

1.7k total citations
32 papers, 1.2k citations indexed

About

Anne Goubier is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Anne Goubier has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 14 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Anne Goubier's work include Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and CAR-T cell therapy research (6 papers). Anne Goubier is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and CAR-T cell therapy research (6 papers). Anne Goubier collaborates with scholars based in France, Netherlands and Australia. Anne Goubier's co-authors include Bertrand Dubois, Dominique Kaiserlian, Grégoire Joubert, Carine Asselin‐Paturel, Giorgio Trinchieri, F. Villard‐Truc, Ludivine Chapat, Christophe Caux, Smina Aït‐Yahia and Marie Le Borgne and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

Anne Goubier

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Goubier France 14 846 164 154 150 113 32 1.2k
Olivier Demaria Switzerland 13 744 0.9× 181 1.1× 228 1.5× 94 0.6× 231 2.0× 15 1.2k
Aoi Akitsu Japan 9 882 1.0× 115 0.7× 240 1.6× 118 0.8× 156 1.4× 16 1.2k
Jan C. Dudda Germany 16 1.3k 1.5× 86 0.5× 305 2.0× 207 1.4× 264 2.3× 19 1.7k
Annelie Tjernlund Sweden 18 1.1k 1.3× 266 1.6× 148 1.0× 188 1.3× 100 0.9× 45 1.5k
Valentina Salucci Italy 9 479 0.6× 113 0.7× 251 1.6× 58 0.4× 80 0.7× 9 851
Sven Mostböck Austria 19 541 0.6× 91 0.6× 238 1.5× 205 1.4× 36 0.3× 36 991
María‐Luisa del Rio Spain 16 1.0k 1.2× 155 0.9× 133 0.9× 214 1.4× 23 0.2× 41 1.3k
Francesca Zonin France 7 995 1.2× 211 1.3× 312 2.0× 159 1.1× 46 0.4× 7 1.3k
Suzanne E. Connaughton United States 8 1.4k 1.6× 246 1.5× 203 1.3× 325 2.2× 60 0.5× 8 1.7k
Joseph R. Maxwell United States 13 774 0.9× 111 0.7× 242 1.6× 122 0.8× 47 0.4× 18 1.2k

Countries citing papers authored by Anne Goubier

Since Specialization
Citations

This map shows the geographic impact of Anne Goubier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Goubier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Goubier more than expected).

Fields of papers citing papers by Anne Goubier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Goubier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Goubier. The network helps show where Anne Goubier may publish in the future.

Co-authorship network of co-authors of Anne Goubier

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Goubier. A scholar is included among the top collaborators of Anne Goubier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Goubier. Anne Goubier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jongen‐Lavrencic, Mojca, Thomas Pabst, Pierre Bories, et al.. (2024). MP0533 (CD33 x CD123 x CD70 x CD3), a Tetra-Specific CD3-Engaging Darpin for the Treatment of Patients with Relapsed/Refractory AML or MDS/AML: Results of an Ongoing Phase 1/2a Study. Blood. 144(Supplement 1). 2881–2881. 4 indexed citations
3.
Bianchi, Matteo, Michael Müller, Yvonne Grübler, et al.. (2024). 842 Unlocking precision: a next-generation multi-specific CD3 Switch-DARPin with enhanced function to tackle the current limitations of T cell engagers in ovarian cancer. Regular and Young Investigator Award Abstracts. A951–A951. 1 indexed citations
4.
Gomez‐Roca, Carlos, Neeltje Steeghs, Eelke Gort, et al.. (2023). Phase I study of MP0317, a FAP-dependent DARPin, for tumor-localized CD40 activation in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 2584–2584. 3 indexed citations
5.
Xiang, Sue D., et al.. (2018). Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8+ T Cell Responses. Frontiers in Immunology. 9. 2968–2968. 28 indexed citations
6.
7.
Nguyen, Thi H. O., Amabel C. L. Tan, Sue D. Xiang, et al.. (2017). Understanding CD8+ T‐cell responses toward the native and alternate HLA‐A∗02:01‐restricted WT1 epitope. Clinical & Translational Immunology. 6(3). e134–e134. 15 indexed citations
8.
9.
Damme, Pierre Van, Ilse De Coster, Christophe Depuydt, et al.. (2016). GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial. Clinical Cancer Research. 22(13). 3238–3248. 34 indexed citations
10.
Dewulf, Jeroen, Tom Meyns, C. Andréoni, et al.. (2016). Effect of sow vaccination against porcine circovirus type 2 (PCV2) on virological profiles in herds with or without PCV2 systemic disease.. PubMed. 57(6). 619–28. 12 indexed citations
11.
Tan, Amabel C. L., Anne Goubier, & Holbrook E. Kohrt. (2015). A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial. Journal for ImmunoTherapy of Cancer. 3(1). 48–48. 26 indexed citations
12.
Goubier, Anne, et al.. (2014). 130 Preclinical results of ProCervix, a first in class, first in indication therapeutic vaccine targeting HPV16/18 infected women. European Journal of Cancer. 50. 45–45. 1 indexed citations
13.
14.
Goubier, Anne, Marc Vocanson, Gaelle Poyet, et al.. (2012). Invariant NKT Cells Suppress CD8+ T-Cell–Mediated Allergic Contact Dermatitis Independently of Regulatory CD4+ T Cells. Journal of Investigative Dermatology. 133(4). 980–987. 29 indexed citations
15.
Dubois, Bertrand, et al.. (2009). Sequential Role of Plasmacytoid Dendritic Cells and Regulatory T Cells in Oral Tolerance. Gastroenterology. 137(3). 1019–1028. 72 indexed citations
16.
17.
Goubier, Anne, Bertrand Dubois, Grégoire Joubert, et al.. (2008). Plasmacytoid Dendritic Cells Mediate Oral Tolerance. Immunity. 29(3). 464–475. 301 indexed citations
18.
Borgne, Marie Le, Nathalie Etchart, Anne Goubier, et al.. (2006). Dendritic Cells Rapidly Recruited into Epithelial Tissues via CCR6/CCL20 Are Responsible for CD8+ T Cell Crosspriming In Vivo. Immunity. 24(2). 191–201. 314 indexed citations
19.
Dubois, Bertrand, Anne Goubier, G Joubert, & D. Kaiserlian. (2005). Intestinal epithelial barrier and mucosal immunity. Cellular and Molecular Life Sciences. 62(12). 1322–1332. 51 indexed citations
20.
Dubois, Bertrand, Ludivine Chapat, Anne Goubier, et al.. (2003). Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood. 102(9). 3295–3301. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Demaria Breakdown of academic impact, for papers by Aoi Akitsu Breakdown of academic impact, for papers by Jan C. Dudda Breakdown of academic impact, for papers by Annelie Tjernlund Breakdown of academic impact, for papers by Valentina Salucci Breakdown of academic impact, for papers by Sven Mostböck Breakdown of academic impact, for papers by María‐Luisa del Rio Breakdown of academic impact, for papers by Francesca Zonin Breakdown of academic impact, for papers by Suzanne E. Connaughton Breakdown of academic impact, for papers by Joseph R. Maxwell
Rankless by CCL
2026